Cardinal Health stock trades at EUR 226.05 with USD 58.2 billion value

Published on 10/27/2026 at 10:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock costs EUR 226.05 on October 27, 2026. Its USD 58.2 billion value frames the quote against a USD 161.36-259.21 range.

CVS agreement supports long-term visibility

Cardinal Health extended its CVS distribution agreement through June 30, 2032, under the October 1, 2026 letter of intent.
Cardinal Health carried a USD 58.2 billion market capitalization as of October 26, 2026.
Cardinal Health stock traded at EUR 226.05 at 10:45 a.m. CET at Lang & Schwarz on October 27, 2026.

Cardinal Health, US14149Y1082, Illustration mit AI erstellt.

At EUR 226.05, Cardinal Health stock was trading at Lang & Schwarz on October 27, 2026, at 10:45 a.m. CET. The current market picture combines a USD 58.2 billion market capitalization with a USD 161.36 to USD 259.21 52-week range from the latest primary-market quote.

CVS agreement sets a long horizon

The most recent company event remains Cardinal Health's October 1, 2026 agreement with CVS Health. According to Cardinal Health, the binding letter of intent extends the existing pharmaceutical distribution agreements through June 30, 2032.

The release ties that extension to fiscal 2027 non-GAAP earnings per share guidance of 13 percent to 15 percent growth, or USD 12.40 to USD 12.60. It also retains a long-term non-GAAP earnings per share growth outlook of 12 percent to 14 percent, giving the contract a measurable connection to management's medium-term planning.

What comes next for results?

Cardinal Health is scheduled to publish first-quarter fiscal 2027 results on November 5, 2026, before trading begins in New York, followed by an investor webcast at 8:30 a.m. Eastern. The date was announced by Cardinal Health on October 1, 2026.

For investors, the November report will provide the next test of the guidance range and the operating contribution from the CVS relationship. Cardinal Health's primary listing is on the NYSE, while its business spans pharmaceutical distribution, medical products and healthcare services.

Stock valuation stays central

The quote sits below the USD 259.21 52-week high and above the USD 161.36 low, a broad valuation frame for the current euro indication. The market capitalization was USD 58.2 billion as of October 26, 2026, while the latest annual financial data place fiscal 2026 revenue at USD 254.25 billion and net income attributable to common shareholders at USD 1.71 billion.

Cardinal Health was trading at EUR 226.05 at Lang & Schwarz on October 27, 2026, at 10:45 a.m. CET.

The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.